166 related articles for article (PubMed ID: 36476110)
21. Development and Validation of a CT-Based Signature for the Prediction of Distant Metastasis Before Treatment of Non-Small Cell Lung Cancer.
Tao J; Lv R; Liang C; Fang J; Liu D; Lan X; Huang H; Zhang J
Acad Radiol; 2022 Feb; 29 Suppl 2():S62-S72. PubMed ID: 33402298
[TBL] [Abstract][Full Text] [Related]
22. Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer.
Tang X; Xu X; Han Z; Bai G; Wang H; Liu Y; Du P; Liang Z; Zhang J; Lu H; Yin H
Biomed Eng Online; 2020 Jan; 19(1):5. PubMed ID: 31964407
[TBL] [Abstract][Full Text] [Related]
23. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer.
Cong M; Feng H; Ren JL; Xu Q; Cong L; Hou Z; Wang YY; Shi G
Lung Cancer; 2020 Jan; 139():73-79. PubMed ID: 31743889
[TBL] [Abstract][Full Text] [Related]
24. CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapy.
Yang F; Zhang J; Zhou L; Xia W; Zhang R; Wei H; Feng J; Zhao X; Jian J; Gao X; Yuan S
Eur Radiol; 2022 Mar; 32(3):1538-1547. PubMed ID: 34564744
[TBL] [Abstract][Full Text] [Related]
25. Combining computed tomography and biologically effective dose in radiomics and deep learning improves prediction of tumor response to robotic lung stereotactic body radiation therapy.
Avanzo M; Gagliardi V; Stancanello J; Blanck O; Pirrone G; El Naqa I; Revelant A; Sartor G
Med Phys; 2021 Oct; 48(10):6257-6269. PubMed ID: 34415574
[TBL] [Abstract][Full Text] [Related]
26. Dosimetric Factors and Radiomics Features Within Different Regions of Interest in Planning CT Images for Improving the Prediction of Radiation Pneumonitis.
Jiang W; Song Y; Sun Z; Qiu J; Shi L
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1161-1170. PubMed ID: 33548340
[TBL] [Abstract][Full Text] [Related]
27. Identification of Non-Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics.
Dercle L; Fronheiser M; Lu L; Du S; Hayes W; Leung DK; Roy A; Wilkerson J; Guo P; Fojo AT; Schwartz LH; Zhao B
Clin Cancer Res; 2020 May; 26(9):2151-2162. PubMed ID: 32198149
[TBL] [Abstract][Full Text] [Related]
28. Radiomics Nomogram for Predicting Locoregional Failure in Locally Advanced Non-small Cell Lung Cancer Treated with Definitive Chemoradiotherapy.
Chen X; Tong X; Qiu Q; Sun F; Yin Y; Gong G; Xing L; Sun X
Acad Radiol; 2022 Feb; 29 Suppl 2():S53-S61. PubMed ID: 33308945
[TBL] [Abstract][Full Text] [Related]
29. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
[TBL] [Abstract][Full Text] [Related]
30. Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB-III non-small cell lung cancer patients using radiomic features.
Yang N; Yue HL; Zhang BH; Chen J; Chu Q; Wang JX; Yu XP; Jian L; Bin YW; Liu SY; Liu J; Zeng L; Yang HY; Zhou CH; Jiang WJ; Liu L; Zhang YC; Xiong Y; Wang Z
Thorac Cancer; 2023 Oct; 14(28):2869-2876. PubMed ID: 37596822
[TBL] [Abstract][Full Text] [Related]
31. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
[TBL] [Abstract][Full Text] [Related]
32. A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
Yang H; Wang L; Shao G; Dong B; Wang F; Wei Y; Li P; Chen H; Chen W; Zheng Y; He Y; Zhao Y; Du X; Sun X; Wang Z; Wang Y; Zhou X; Lai X; Feng W; Shen L; Qiu G; Ji Y; Chen J; Jiang Y; Liu J; Zeng J; Wang C; Zhao Q; Yang X; Hu X; Ma H; Chen Q; Chen M; Jiang H; Xu Y
Front Oncol; 2022; 12():967360. PubMed ID: 35982975
[TBL] [Abstract][Full Text] [Related]
33. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients.
Yang L; Yang J; Zhou X; Huang L; Zhao W; Wang T; Zhuang J; Tian J
Eur Radiol; 2019 May; 29(5):2196-2206. PubMed ID: 30523451
[TBL] [Abstract][Full Text] [Related]
34. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
[TBL] [Abstract][Full Text] [Related]
35. Radiomics for Survival Risk Stratification of Clinical and Pathologic Stage IA Pure-Solid Non-Small Cell Lung Cancer.
Wang T; She Y; Yang Y; Liu X; Chen S; Zhong Y; Deng J; Zhao M; Sun X; Xie D; Chen C
Radiology; 2022 Feb; 302(2):425-434. PubMed ID: 34726531
[TBL] [Abstract][Full Text] [Related]
36. Differentiating the pathological subtypes of primary lung cancer for patients with brain metastases based on radiomics features from brain CT images.
Zhang J; Jin J; Ai Y; Zhu K; Xiao C; Xie C; Jin X
Eur Radiol; 2021 Feb; 31(2):1022-1028. PubMed ID: 32822055
[TBL] [Abstract][Full Text] [Related]
37. Risk analysis of grade ≥ 2 radiation pneumonitis based on radiotherapy timeline in stage III/IV non-small cell lung cancer treated with volumetric modulated arc therapy: a retrospective study.
Yang S; Huang S; Ye X; Xiong K; Zeng B; Shi Y
BMC Pulm Med; 2022 Nov; 22(1):402. PubMed ID: 36344945
[TBL] [Abstract][Full Text] [Related]
38. Can radiomics help to predict skeletal muscle response to chemotherapy in stage IV non-small cell lung cancer?
de Jong EEC; Sanders KJC; Deist TM; van Elmpt W; Jochems A; van Timmeren JE; Leijenaar RTH; Degens JHRJ; Schols AMWJ; Dingemans AC; Lambin P
Eur J Cancer; 2019 Oct; 120():107-113. PubMed ID: 31514107
[TBL] [Abstract][Full Text] [Related]
39. A prognostic analysis method for non-small cell lung cancer based on the computed tomography radiomics.
Wang X; Duan H; Li X; Ye X; Huang G; Nie S
Phys Med Biol; 2020 Feb; 65(4):045006. PubMed ID: 31962301
[TBL] [Abstract][Full Text] [Related]
40. Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis.
Kawahara D; Imano N; Nishioka R; Ogawa K; Kimura T; Nakashima T; Iwamoto H; Fujitaka K; Hattori N; Nagata Y
Sci Rep; 2021 Aug; 11(1):16232. PubMed ID: 34376721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
